GGrantIndex
← Leaderboards

Michael Tranter

University Of Cincinnati

$5,318,021
Attributed
$6,327,163
Total exposure
3
Grants
3
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.3M · FY201625
$2M$1.5M$1M$500K$0
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$6,327,163 · 3

By mechanism

R01$6,327,163 · 3

Top collaborators

Most similar at University Of Cincinnati

Same institution · by research overlap

Others in their field

Top investigators on “Cardiac Myocytes

Research focus

Cardiac MyocytesGeneticMouse ModelSignal TransductionCardiacMediatingIn VivoRna-Binding ProteinsAntigensKnock-DownOverexpressionHeart FunctionMuscle CellsLaboratoriesVentricularRattusHeart HypertrophyGenesNeonatalPathologyProteinsChronicAffectMyocardial

Grant awards (12)

Functional and mechanistic delineation of HuR-Wisp1 signaling on myofibroblast activity$649,059
R01 · FY2025 · HL · contact PI
Post-transcriptional control of adipose tissue gene expression as an endocrine mediator of cardiac pathology$623,770
R01 · FY2025 · HL · contact PI
Functional and mechanistic delineation of HuR-Wisp1 signaling on myofibroblast activity$650,453
R01 · FY2024 · HL · contact PI
Post-transcriptional control of adipose tissue gene expression as an endocrine mediator of cardiac pathology$621,989
R01 · FY2024 · HL · contact PI
Functional and mechanistic delineation of HuR-Wisp1 signaling on myofibroblast activity$718,773
R01 · FY2023 · HL · contact PI
Post-transcriptional control of adipose tissue gene expression as an endocrine mediator of cardiac pathology$629,313
R01 · FY2023 · HL · contact PI
Post-transcriptional control of adipose tissue gene expression as an endocrine mediator of cardiac pathology$656,306
R01 · FY2022 · HL · contact PI
Investigation of Human Antigen R (HuR) as a Novel Mediator of Cardiac Hypertrophy$355,500
R01 · FY2020 · HL · contact PI
Investigation of Human Antigen R (HuR) as a Novel Mediator of Cardiac Hypertrophy$355,500
R01 · FY2019 · HL · contact PI
Investigation of Human Antigen R (HuR) as a Novel Mediator of Cardiac Hypertrophy$355,500
R01 · FY2018 · HL · contact PI
Investigation of Human Antigen R (HuR) as a Novel Mediator of Cardiac Hypertrophy$355,500
R01 · FY2017 · HL · contact PI
Investigation of Human Antigen R (HuR) as a Novel Mediator of Cardiac Hypertrophy$355,500
R01 · FY2016 · HL · contact PI